Emergent BioSolutions
EBS
#6775
Rank
HK$5.06 B
Marketcap
HK$94.94
Share price
-1.78%
Change (1 day)
29.58%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: HK$5.06 Billion

As of January 2026 Emergent BioSolutions has a market cap of HK$5.06 Billion. This makes Emergent BioSolutions the world's 6775th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$5.06 B-1.84%
2025HK$5.15 B48.32%
2024HK$3.47 B257.71%
2023HK$0.97 B-78.87%
2022HK$4.60 B-74.76%
2021HK$18.23 B-50.46%
2020HK$36.81 B69.47%
2019HK$21.72 B-8.6%
2018HK$23.76 B31.2%
2017HK$18.11 B75.65%
2016HK$10.31 B-15.61%
2015HK$12.22 B53.43%
2014HK$7.96 B21.99%
2013HK$6.52 B46.4%
2012HK$4.45 B-5.16%
2011HK$4.70 B-26.43%
2010HK$6.39 B96.75%
2009HK$3.24 B-46.19%
2008HK$6.03 B414.35%
2007HK$1.17 B-51%
2006HK$2.39 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Emergent BioSolutions was reported to be:

HK$5.08 Billion
by Nasdaq info icon info icon
HK$5.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
HK$2.109 T 41,547.49%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$3.68 B-27.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$786.73 B 15,432.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
HK$13.44 B 165.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.115 T 21,923.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$290.60 B 5,637.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
HK$0.10 B-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA